Prellis Biologics and CELLINK Sign Partnership

Prellis Biologics and CELLINK sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing.

The partners will utilize their IP, expertise, and know-how to offer the first system enabling ultra-high resolution bioprinting of microsctructures such as vascular networks or capillaries. The technology is an important complement to CELLINKs extrusion based bioprinting platform, enabling combined prints from the two printing technologies for anatomically relevant results.

Prellis Biologics has developed a proprietary ultra-fast, multi-photon laser-based bioprinting technology in fifteen months of tenancy at MBC BioLabs San Francisco. Live-cell imaging methods inspired the creation of a tissue printing system designed to replicate real human tissue structures, at never-before seen resolutions.
Full Press Release